Primary Intraocular Lymphoma: Rad-Path and Ophthalmologic Correlation

References

1. 1.↵
   1. Venkatesh R,
   2. Bavaharan B,
   3. Mahendradas P, et al

   . Primary vitreoretinal lymphoma: prevalence, impact, and management challenges. Clin Ophthalmol 2019;13:353–64 doi:10.2147/OPTH.S159014 pmid:30858685

   CrossRefPubMed
2. 2.↵
   1. Simakurthy S,
   2. Jena S,
   3. Tripathy K

   . Primary intraocular lymphoma. In StatPearls; Treasure Island (FL): StatPearls Publishing; 2024
3. 3.↵
   1. Levasseur SD,
   2. Wittenberg LA,
   3. White VA

   . Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes. JAMA Ophthalmol 2013;131:50–55 doi:10.1001/jamaophthalmol.2013.569 pmid:23307208

   CrossRefPubMed
4. 4.↵
   1. Fardeau C,
   2. Lee CPL,
   3. Merle-Béral H, et al

   . Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin primary intraocular lymphoma. Am J Ophthalmol 2009;147:886–94.e1 doi:10.1016/j.ajo.2008.12.025 pmid:19243734

   CrossRefPubMed
5. 5.↵
   1. Zhao XY,
   2. Cheng TT,
   3. Meng LH, et al

   . Clinical features, diagnosis, management and prognosis of primary intraocular lymphoma. Front Oncol 2022;12:808511 doi:10.3389/fonc.2022.808511 pmid:35186744

   CrossRefPubMed
6. 6.↵
   1. Capasso R,
   2. Negro A,
   3. Russo C, et al

   . Conventional and advanced MRI techniques in the evaluation of primary CNS lymphoma. Semin Ultrasound CT MR 2023;44:126–35 doi:10.1053/j.sult.2023.02.003 pmid:37245879

   CrossRefPubMed
7. 7.↵
   1. Cheng G,
   2. Zhang J

   . Imaging features (CT, MRI, MRS, and PET/CT) of primary central nervous system lymphoma in immunocompetent patients. Neurol Sci 2019;40:535–42 doi:10.1007/s10072-018-3669-7 pmid:30580380

   CrossRefPubMed
8. 8.↵
   1. Echegaray JJ,
   2. Llop S,
   3. Sepulveda M, et al

   . Intravitreal rituximab for the treatment of a secondary intraocular relapse of a large B-cell lymphoma. Am J Ophthalmol Case Rep 2018;9:77–79 doi:10.1016/j.ajoc.2018.01.032 pmid:29577096

   CrossRefPubMed
9. 9.↵
   1. Kuker W,
   2. Herrlinger U,
   3. Gronewaller E, et al

   . Ocular manifestation of primary nervous system lymphoma: what can be expected from imaging? J Neurol 2002;249:1713–16 doi:10.1007/s00415-002-0919-6 pmid:12529795

   CrossRefPubMed
10. 10.↵
    1. Küker W,
    2. Nägele T,
    3. Korfel A, et al

    . Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neurooncol 2005;72:169–77 doi:10.1007/s11060-004-3390-7

    CrossRefPubMed
11. 11.↵
    1. He LF,
    2. Zhang JD,
    3. Chen XX, et al

    . Epidemiology and survival outcomes of patients with primary intraocular lymphoma: a population-based analysis. BMC Ophthalmol 2022;22:486 doi:10.1186/s12886-022-02702-6 pmid:36514001

    CrossRefPubMed
12. 12.↵
    1. Alsberge JB,
    2. Johnson RN

    . Vitreoretinal lymphoma following primary testicular lymphoma: report of two cases and review of the literature. Am J Ophthalmol Case Rep 2021;24:101218 doi:10.1016/j.ajoc.2021.101218 pmid:34667896

    CrossRefPubMed
13. 13.↵
    1. Bedaiwi K,
    2. Alfawaz AM,
    3. Mohammed SF, et al

    . Intraocular T-cell lymphoma metastasizing from a primary adrenal T-cell lymphoma: case report. Ann Med Surg (Lond) 2020;60:646–50 doi:10.1016/j.amsu.2020.11.066 pmid:33304580

    CrossRefPubMed
14. 14.↵
    1. Parikh AH,
    2. Khan SH,
    3. Wright JD Jr., et al

    . Systemic non-Hodgkin’s lymphoma simulating primary intraocular lymphoma. Am J Ophthalmol 2005;139:573–74 doi:10.1016/j.ajo.2004.09.047 pmid:15767087

    CrossRefPubMed
15. 15.↵
    1. Cunningham ET,
    2. Miserocchi E,
    3. Smith JR, et al

    . Intraocular lymphoma. Ocul Immunol Inflamm 2021;29:425–29 doi:10.1080/09273948.2021.1941684 pmid:34296968

    CrossRefPubMed
16. 16.↵
    1. Tang LJ,
    2. Gu CL,
    3. Zhang P

    . Intraocular lymphoma. Int J Ophthalmol 2017;10:1301–07 doi:10.18240/ijo.2017.08.19 pmid:28861359

    CrossRefPubMed
17. 17.↵
    1. Kuro M,
    2. Matsuyama K,
    3. Matsuoka M, et al

    . Case of primary intraocular lymphoma with extraocular extension. Ocul Oncol Pathol 2015;2:66–70 doi:10.1159/000439053 pmid:27171820

    CrossRefPubMed
18. 18.↵
    1. Parikh SA,
    2. Kay NE,
    3. Shanafelt TD

    . How we treat Richter syndrome. Blood 2014;123:1647–57 doi:10.1182/blood-2013-11-516229 pmid:24421328

    Abstract/FREE Full Text
19. 19.↵
    1. Mota PM,
    2. Dedes W,
    3. Yeoh SL, et al

    . Ocular lymphoma with extrascleral extension as primary manifestation of Richter syndrome. Eye (Lond) 2012;26:891–93 doi:10.1038/eye.2012.41 pmid:22422034

    CrossRefPubMed
20. 20.↵
    1. Sagoo MS,
    2. Mehta H,
    3. Swampillai AJ, et al

    . Primary intraocular lymphoma. Surv Ophthalmol 2014;59:503–16 doi:10.1016/j.survophthal.2013.12.001 pmid:24560125

    CrossRefPubMed
21. 21.↵
    1. Coupland SE,
    2. Chan CC,
    3. Smith J

    . Pathophysiology of retinal lymphoma. Ocul Immunol Inflamm 2009;17:227–37 doi:10.1080/09273940903168696 pmid:19657975

    CrossRefPubMed
22. 22.↵
    1. Lopes PG,
    2. Ferreira FC,
    3. Christofoletti T, et al

    . Primary intraocular lymphoma: case report and proposed diagnostic algorithm. Hematol Transfus Cell Ther 2023;45:505–09 doi:10.1016/j.htct.2021.11.016 pmid:35105530

    CrossRefPubMed
23. 23.↵
    1. D’Souza MM,
    2. Jaimini A,
    3. Bansal A, et al

    . FDG-PET/CT in lymphoma. Indian J Radiol Imaging 2013;23:354–65 doi:10.4103/0971-3026.125626 pmid:24604942

    CrossRefPubMed
24. 24.↵
    1. Grimm SA,
    2. Pulido JS,
    3. Jahnke K, et al

    . Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol 2007;18:1851–55 doi:10.1093/annonc/mdm340 pmid:17804469

    CrossRefPubMed
25. 25.↵
    1. Heiferman MJ,
    2. Yu MD,
    3. Mruthyunjaya P

    . Update in molecular testing for intraocular lymphoma. Cancers (Basel) 2022;14:4546 doi:10.3390/cancers14194546

    CrossRefPubMed
26. 26.↵
    1. Hearne E,
    2. Netzer OT,
    3. Lightman S

    . Learning points in intraocular lymphoma. Eye (Lond) 2021;35:1815–17 doi:10.1038/s41433-021-01500-6 pmid:33731889

    CrossRefPubMed